Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some forms of osteosarcoma. A combination approach described today in the Journal of Experimental Medicine slowed tumor growth and prolonged survival in preclinical models of this pediatric bone cancer. The therapies degraded EP300 (a protein that is co-opted to express oncogenes in many cancers) and inhibited AKT (a well-known cancer drug target), highlighting the combination's clinical potential.
❓ Unknown
Combination Therapy Shows Promise in Treating Aggressive Osteosarcoma
1w ago
October 20, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
Researchers from St. Jude Children's Research Hospital have discovered a combination therapy that shows promise in treating aggressive osteosarcoma, a pediatric bone cancer. This finding could lead to improved treatment options for affected children, which is significant for healthcare advancements in Iran.
🔍 Quick Context Guide
💡 Bottom Line:
The discovery of a promising combination therapy for osteosarcoma could significantly improve survival rates for affected children.
👥 Key Players
St. Jude Children's Research Hospital
MENTIONED
Leading research institution
"They are a prominent center for pediatric research, potentially influencing treatment options for children with cancer in Iran and beyond."
📰 What Happened
Researchers have identified a combination therapy that effectively slows tumor growth and extends survival in preclinical models of osteosarcoma, a type of bone cancer affecting children.
- The therapy targets the EP300 protein and inhibits the AKT pathway, both of which are involved in cancer progression.
- The findings were published in the Journal of Experimental Medicine, indicating a peer-reviewed validation of the research.
💡 Why It Matters
🇮🇷 For Iran: Improved cancer treatment options could enhance healthcare outcomes for Iranian children suffering from osteosarcoma.
🌍 Regional: This research could inspire similar studies in the region, potentially leading to collaborative healthcare advancements.
🌐 International: The findings may attract international interest and funding for pediatric cancer research, influencing global treatment protocols.
📚 Background
Osteosarcoma is a rare but aggressive bone cancer primarily affecting children and adolescents, making effective treatment critical.
Pediatric cancer research
Cancer treatment advancements
📡 Source:
NEUTRAL
📊 Confidence:
70%
The article is based on peer-reviewed research, suggesting a high level of credibility.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Trump: Negotiations with Iran are progressing well but are not trustworthy
12 min ago •
Bolsonaro Has Fled Brazil with the Help of a Former Mossad Agent
18 min ago •
Why Do Some People See Spirits or Sense the Presence of an Invisible Being?
35 min ago •
The Necessity of Public Cooperation with Energy Consumption Management Programs/The Government Must Take Optimization Seriously
41 min ago •